BGI takes aim at HiSeq X with new sequencer; ASCO picks Syapse for precision medicine trial;

> BGI's Complete Genomics signed up the first clients for its HiSeq X Ten-rivaling high-throughput Revolocity sequencing system. More

> ASCO picked Syapse Precision Medicine Platform for its Big Pharma-backed TAPUR study. Item

> The Financial Times profiled 23andMe's Anne Wojcicki, describing the CEO as "the freewheeling queen of home DNA testing." Feature (reg. req.)

> Trinity Pharma Solutions rebranded as SHYFT Analytics following the introduction of the latest iteration of its life sciences analytics platform. Release

> Chris4Life Colon Cancer Foundation created a colon cancer-focused clinical trial database to make it easier for people to participate in research. News (PDF)

> Experfy scooped seed funding to build out its marketplace for freelance data scientists. Article (sub. req.)

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.